March 21st 2025
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans.
March 20th 2025
March 19th 2025
March 18th 2025
March 10th 2025
March 7th 2025
March 6th 2025
March 5th 2025
March 3rd 2025
February 23rd 2025
February 22nd 2025
February 1st 2025